---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-034717"
form_type: "8-K"
ticker: "SNES"
cik: "0001680378"
company_name: "SenesTech, Inc."
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:09:03.391040+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# SenesTech receives Nasdaq non-compliance notice for audit committee independence; cure period granted

## Summary
- Director Delphine François Chiavarini left board and audit committee at 2024 annual meeting, leaving audit committee below three independent members.
- Nasdaq granted cure period until earlier of next annual meeting or July 11, 2025; if annual meeting before Jan 7, 2025, compliance due by Jan 7, 2025.
- Company intends to identify and appoint a new independent director to regain compliance during cure period.
- No immediate effect on common stock listing on Nasdaq Capital Market, but compliance cannot be assured.

## SEC filing metadata
- accession: 0001628280-24-034717
- form_type: 8-K
- ticker: SNES
- cik: 0001680378
- company_name: SenesTech, Inc.
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680378/000162828024034717/0001628280-24-034717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680378/000162828024034717/snes-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-034717
- JSON: https://secwatch.observer/filing/0001628280-24-034717.json
- Plain text: https://secwatch.observer/filing/0001628280-24-034717.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.